PROCEPT BioRobotics CorpPRCT

時価総額
$42.2億
PER
2021年
12月31日
2022年
12月31日
2023年
12月31日
Net loss-60-87-106
Depreciation and amortization33-
Depreciation and amortization--4
Stock-based compensation expense41019
Fair Value Adjustment of Warrants and Gain (Loss) on Derivative Instruments, Net, Pretax-000
Non-cash lease adjustment0-1-0
Inventory write-down101
Loss on loan extinguishment--3-
Accounts receivable, net31133
Inventory61510
Prepaid expenses and other current assets32-1
Other assets-01
Accounts payable146
Accrued compensation273
Accrued interest expense110
Deferred revenue123
Operating lease liabilities-05
Other liabilities23-1
Net cash used in operating activities-57-80-108
Purchases of property and equipment1325
Net cash used in investing activities-1-3-25
Proceeds from Issuance of Common Stock-2162
Proceeds from Repayment of Loans by Employee Stock Ownership Plans--4
Proceeds from Stock Options Exercised442
Proceeds from Issuance Initial Public Offering172--
Proceeds from Debt, Net of Issuance Costs-51-
Proceeds from Issuance of Common Stock-2162
Proceeds from Warrant Exercises1--
Proceeds from Issuance of Redeemable Convertible Preferred Stock, Net of Issuance Costs85--
Payment of principal on long-term debt-50-
Proceeds from Debt, Net of Issuance Costs-51-
Payment of final payment fee-3-
Payment of principal on long-term debt-50-
Payment of prepayment fee-1-
Payment of final payment fee-3-
Net cash provided by financing activities2624168
Payment of prepayment fee-1-
Net cash provided by financing activities2624168
Net increase (decrease) in cash, cash equivalents and restricted cash204-7935
Interest paid544
Transfer From Inventory to Property and Equipment, Net-100
Capital Expenditures Incurred but Not yet Paid042
Conversion of Stock, Amount Converted330--
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability-23-
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability-23-
Conversion of Stock, Amount Converted330--